Cargando…
P1696: HEMOSTATIC ACTIVATION MARKERS AND SEROLOGICAL RESPONSE IN SUBJECTS RECEIVING ANTI-COVID-19 VACCINATION
Autores principales: | Schieppati, F., Gamba, S., Galimberti, E., Russo, L., Giaccherini, C., Bolognini, S., Tartari, C. J., Ticozzi, C., Palladino, A. M., Cretu, O. C., Barcella, L., Marchetti, M., Falanga, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430494/ http://dx.doi.org/10.1097/01.HS9.0000849640.97953.ed |
Ejemplares similares
-
Hemostatic Markers, Adamts-13 Profile and Anti-Sars-Cov-2 Antibody Levels in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving BNT162b2 Vaccination
por: Schieppati, Francesca, et al.
Publicado: (2021) -
Inflammatory and Coagulation Biomarkers in Patients with Sars-COV2 Infection Receiving COVID-19 Convalescent Plasma: The Bergamo Registry
por: Marchetti, Marina, et al.
Publicado: (2022) -
Role of Hemostatic Biomarkers for the Identification of Patients with LONG-COVID19 Syndrome: Results from the 'Accordi' Study
por: Ambaglio, Chiara, et al.
Publicado: (2022) -
P1675: POST-HOSPITAL DISCHARGE EVALUATION OF COVID-19 SURVIVORS WHO SUFFERED ACUTE VENOUS THROMBOEMBOLISM (VTE) DURING HOSPITALIZATION: THE BERGAMO EXPERIENCE
por: Ambaglio, C., et al.
Publicado: (2022) -
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients
por: Gomez-Rosas, Patricia, et al.
Publicado: (2023)